CharlieAJA Hims & Hers Health ( NYSE: HIMS ) raised its full-year net revenue outlook to $1.37B-$1.4B, above the consensus estimate of $1.
28B. Despite the raise, shares are down ~11% in after-hours trading Monday even as the telehealth provider's Q2 financial results beat on both lines . Hims & Hers benefitted in the quarter from a 43% year-over-year growth in subscribers to ~1.
9M. Revenue per subscriber increased 8% YoY. The company swung to net income in the quarter of ~$13.
3M compared to a loss of ~$7.3M in the year-ago period ($0.06 EPS basic and diluted vs.
-$0.03). Hims & Hers ended the quarter with cash, cash equivalents, and short-term investments of ~$227.
3M compared to ~$221M on Dec. 31, 2023. More on Hims & Hers Health Hims & Hers Health: Expecting A Healthy Report Hims & Hers Health: Built On Successful Branding Hims & Hers: The Thesis Goes Far Beyond GLP-1 Hims & Hers Health GAAP EPS of $0.
06 beats by $0.01, revenue of $315.65M beats by $13.
22M Hims & Hers Health Q2 2024 Earnings Preview.
